We are thrilled to announce that Satya Pharma Innovations has been officially recognized by the Department of Scientific and Industrial Research (DSIR), Government of India, as of 28th March 2025.
This recognition is a significant milestone that affirms our commitment to excellence in research and development. With this accreditation, our in-house R&D units are now authorized for customs duty exemption on the import of research-related equipment and materials—a move that will further accelerate our innovation pipeline.
The DSIR recognition not only validates the quality and capability of our scientific infrastructure but also empowers us to deepen our contributions to the pharmaceutical sector through cutting-edge innovation and technology.
We extend our heartfelt thanks to our dedicated R&D teams and stakeholders who made this achievement possible. Here’s to pushing the boundaries of pharmaceutical innovation!
Leave A Comment